Skip to main content
. 2020 Nov 25;12(12):3508. doi: 10.3390/cancers12123508

Table 2.

Distribution of normal PB leukocyte subsets in T/NK-LGLL according to their STAT3 or STAT5B mutational status.

Cell Populations Age-Matched HD
(n = 628)
T/NK-LGLL p-Value
Wild-Type STAT3 and STAT5B (n = 32) STAT3 or STAT5B Mutated (n = 18)
Granulocytes (/µL) 3977 (1678–8717) 2503 (298–10,264) 1308 (46–6676) ≤0.008 abc
Neutrophils 3709 (1563–8542) 2301 (263–10,072) 1217 (39–4974) ≤0.01 abc
Eosinophils 161 (0–876) 143 (8.4–1402) 30 (1.5–1250) ≤0.03 abc
Basophils 41 (2.2–222) 51 (7.7–161) 33 (4.3–452) 0.02 a; 0.1 c
Monocytes (/µL) 320 (66–1247) 435 (23–1522) 443 (150–1783) 0.0001 a; 0.06 b
cMO 419 (215–1063) 400 (13–1426) 366 (128–1778) NS
ncMO 67 (20–166) 43 (0–225) 40 (0.49–149) ≤0.05 ab
Dendritic cells (/µL) 24 (4.1–124) 17 (0–54) 8.2 (0.7–105) ≤0.05 abc
Lymphocytes (/µL) 1653 (0–5947) 2084 (943–7547) 1342 (553–4446) 0.02 ac; 0.08 b
T lymphocytes (/µL) 1188 (371–5298) 1672 (655–6469) 1109 (291–4039) ≤0.05 ac
TCD8+ 386 (13–2199) 463 (0–3133) 308 (38–2120) NS
TCD4+ 695 (106–3224) 970 (88–3994) 686 (227–2221) ≤0.05 ac
Tαβ+DP 8.6 (0–180) 28 (2.2–341) 24 (3.3–200) ≤0.05 ab
Tαβ+DN 15 (2–117) 16 (2.2–94) 13 (5.3–104) NS
Tγδ+ 47 (1–765) 26 (0–598) 17 (0–265) 0.002 b; 0.06 c
NK cells (/µL) 279 (0–1215) 150 (2–1383) 48 (0–408) ≤0.006 abc
CD56−/+lo 5.2 (1.1–19) 2.6 (0–328) 2.6 (0–44) NS
CD56+ 350 (116–773) 144 (0–1372) 30 (0–403) ≤0.002 abc
CD56++ 4.5 (1.4–25) 7.8 (1.3–93) 5.5 (0–46) 0.08a
B lymphocytes (/µL) 141 (8.1–867) 177 (9.9–970) 147 (15–409) NS
Plasma cells (/µL) 1.3 (0.104–14) 1.2 (0.091–28) 1.1 (0–14) NS

Results expressed as median (range) values. In bold: statistically significant differences (p-value ≤ 0.05). a HD vs. WT cases; b HD vs. STAT3/5B-mutated cases; c STAT3/5B-mutated vs. WT cases. Abbreviations (alphabetical order): HD, healthy donor; c, classical; LGLL, leukemia of large granular lymphocytes; MO, monocyte; nc, nonclassical; NS, no statistically significant differences (p-value > 0.05); PB, peripheral blood.